Fast MRI for diagnosing brain tumors in children
Fast Brain MRI in Children With Suspected or Confirmed Brain Tumor
This study is testing a new fast MRI method called Neuromix to see if it can better diagnose brain tumors in children compared to regular MRI scans.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 1 Month to 18 Years |
| Sex | All |
| Sponsor | Karolinska University Hospital Academic / other |
| Locations | 1 site (Stockholm) |
| Trial ID | NCT05776602 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a new fast MRI technique called Neuromix in diagnosing brain tumors in pediatric patients compared to standard clinical MRI. It focuses on assessing the accuracy of Neuromix in depicting normal brain structures, tumor pathology, and incidental findings. The study will measure sensitivity, specificity, and agreement between different readers, while also examining image quality and artifacts. Participants aged 0-18 with suspected or diagnosed brain tumors will undergo both Neuromix and routine MRI on the same day.
Who should consider this trial
Good fit: Ideal candidates are pediatric patients aged 0-18 with suspected or diagnosed brain tumors referred for routine MRI.
Not a fit: Patients who are undergoing MRI without sedation or those with unstable conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to quicker and more accurate diagnoses of brain tumors in children, improving treatment outcomes.
How similar studies have performed: Other studies have shown promising results with advanced MRI techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 0-18 years. * Pediatric subjects with diagnosed or suspected brain tumor * Referral routine MRI study. Exclusion Criteria: * MRI planned without sedation * Aborted MR exam * Unstable patient
Where this trial is running
Stockholm
- Karolinksa Universitetssjukhuset — Stockholm, Sweden (Recruiting)
Study contacts
- Principal investigator: Anna Falk Delgado, Ass Prof — Karolinska Institutet
- Study coordinator: Anna Falk Delgado
- Email: anna.falk.delgado@ki.se
- Phone: 0046812370000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.